Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 112th Annual Digestive Disease Week
Colon Cancer Prevention: From Prophylaxis in UC Patients to Adequate Bowel Preparation for Colonoscopy
Chicago, Illinois / May 7-10, 2011
Chicago - New data are providing guidance for further improving already important strategies for the prevention of colorectal cancer. As demonstrated here at DDW, in one series of studies, the effort to isolate a therapeutic mechanism which...
PRIORITY PRESS - 13th International Myeloma Workshop
Increasing Response and Reducing Adverse Events: An Exploration of Dosing Schedules and Combination Therapies for Multiple Myeloma
Paris, France / May 3-6, 2011
Paris - Proteasome inhibitor-containing regimens have improved response rates and response duration across all disease stages of multiple myeloma (MM) in transplant-eligible and -ineligible patients. New data presented here at the Myeloma...
PRIORITY PRESS - 26th Annual Congress of the European Association of Urology
Importance of Rapid and Profound Suppression of Hormone Levels in Prostate Cancer Now Supported by PSA Progression-free Survival
Vienna, Austria / March 18-22, 2011
Vienna - Newly released data from an ongoing extension study demonstrate outcome advantages for an antagonist relative to an agonist of gonadotropin-releasing hormone (GnRH) for prostate cancer. Specifically, patients switched to an...
RESOURCE LINE
VACCINE
January-March 2011
Prophylactic use of the quadrivalent HPV prevents external genital lesions in boys and men Giuliano et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011;364(5):401-11,...
MEDICAL FRONTIERS - 2011 Gastrointestinal Cancer Symposium
Applying Mutation Analysis to Treatment of GIST
San Francisco, California / January 20-22, 2011
Mutations in KIT play the most important role in gastrointestinal stromal tumours (GISTs), according to Dr. Christopher Corless, Oregon Health and Science University, Portland. Much of the influence occurs on exon 11, which accounts for...
PRIORITY PRESS - 33rd Annual San Antonio Breast Cancer Symposium
The Role of Bisphosphonates in Adjuvant Therapy for Breast Cancer
San Antonio, Texas / December 9-12, 2010
Bisphosphonates (BPs) have a well-established therapeutic role in prevention of skeletal events in cancer patients by impairing malignant osteolysis to interrupt bone destruction and cancer growth. Preclinical studies have suggested that...
PRIORITY PRESS - 33rd Annual San Antonio Breast Cancer Symposium
Aromatase Inhibitors as Upfront Endocrine Therapy in Early Breast Cancer
San Antonio, Texas / December 9-12, 2010
Aromatase inhibitors (AIs) have an established role in adjuvant endocrine therapy for early breast cancer. However, according to Dr. Paul Goss, Massachusetts General Hospital, Harvard Medical School, Boston, structural and molecular...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
HPV Vaccination for Males—Disease Burden Equivalent to Females
Quebec City, Quebec / December 5-8, 2010
Quebec City - Currently, vaccination against the human papillomavirus (HPV) is offered to females between 9 and 26 years of age, but uptake of the vaccine varies from province to province and many young women remain unvaccinated. Many now...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
A First-line Option for Second-generation TKIs in Chronic Myeloid Leukemia
Orlando, Florida / December 4-7, 2010
Orlando - Second-generation tyrosine kinase inhibitors (TKIs) are replacing imatinib as first-line therapy for Philadelphia chromosome-positive chronic myeloid leukemia (CML), according to practice-changing data presented at the ASH...